Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Quanterix Corporation
QTRX | US
3.36
USD0.06
1.82%
QTRX | US
About Quanterix Corporation
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
10/04/2026
Close
3.36
Open
3.30
High
3.36
Low
3.23
Quanterix Corporation a life sciences company engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America Europe the Middle East Africa and the Asia Pacific regions. It offers HD-X instrument a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition it offers contract research services including sample testing homebrew assay development and custom development services. The company primarily operates in the areas of neurology oncology cardiology infectious diseases and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions as well as pharmaceutical biotechnology and contract research companies through a direct sales force support organizations and distributors or sales agents. The company was formerly known as Digital Genomics Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica Massachusetts.
View LessQTRX | US
Risk
61.7
Sharpe
-0.45
Luna's Score
49/100
Recommendation
Hold
Luna says (QTRX | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
78.3%1 month
61.7%3 months
84.9%6 months
72.2%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
1.46
Debt to equity
0.12
Debt to assets
0.10
Ent. to EBITDA
-1.49
Ent. to rev.
1.82
PEG
-
Other Fundamentals
EBITDA
-45.90M
MarketCap
128.95M
MarketCap(USD)
128.95M
Div. yield
-
Op. margin
-38.13
Erngs. growth
-
Rev. growth
10.80
Ret. on equity
-11.48
Short ratio
5.71
Short perc.
6.70
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
0.67
Range1M
1.92
Range3M
5.54
Volumes: Market Activity
Rel. volume
0.82
Price X volume
2.26M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.49 | - | Cheaper |
| Ent. to Revenue | 1.82 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 1.46 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 84.90 | - | Par |
| Debt to Equity | 0.12 | -1.23 | Expensive |
| Debt to Assets | 0.10 | 0.25 | Cheaper |
| Market Cap | 128.95M | - | Emerging |
